This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Epizyme, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Katherine Louise Cosmopoulos: Patent Activity in SETD2 Inhibitors.
Introduction
Katherine Louise Cosmopoulos is an inventor associated with Medford, Massachusetts. Her patent work concerns SETD2 inhibitors and potential therapeutic approaches for treating diseases and disorders.
Latest Patents
Cosmopoulos is named on 1 patent: “SETD2 Inhibitors and Related Methods and Uses, Including Combination Therapies.” The disclosure describes SETD2 protein inhibitors and methods, compositions, and kits for treatment, potentially alongside other therapeutic agents. These agents may include glucocorticoid receptor agonists, immunomodulatory drugs, proteasome inhibitors, Bcl-2 inhibitors, pleiotropic pathway modulators, XPO1 inhibitors, histone deacetylase inhibitors, or EZH2 inhibitors.
Career Highlights
Cosmopoulos is associated with Epizyme, Inc., a biotechnology company. Her listed patent reflects research and development focused on targeted therapeutic strategies.
Collaborations
Vinny Motwani is identified as a coworker. The available information does not specify their particular roles or contributions to the patent.
Conclusion
Katherine Louise Cosmopoulos’s patent activity centers on SETD2 inhibitors and combination therapies, highlighting a contribution to the development of potential treatment approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile